Russell Alan J - Nov 30, 2021 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role
Chief Scientific Officer, Director
Signature
/s/ John R. Moore, Attorney-in-Fact for Russell Alan J
Stock symbol
EWTX
Transactions as of
Nov 30, 2021
Transactions value $
$37,815
Form type
4
Date filed
12/1/2021, 05:20 PM
Previous filing
Nov 17, 2021
Next filing
May 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EWTX Common Stock Options Exercise $26.6K +148K $0.18* 148K Nov 30, 2021 Direct
transaction EWTX Common Stock Options Exercise $11.3K +25K +16.94% $0.45* 173K Nov 30, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EWTX Stock Option (Right to Buy) Options Exercise $0 -148K -100% $0.00* 0 Nov 30, 2021 Common Stock 148K $0.18 Direct F1
transaction EWTX Stock Option (Right to Buy) Options Exercise $0 -25K -16.09% $0.00 130K Nov 30, 2021 Common Stock 25K $0.45 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares subject to the option vested on July 27, 2018 and 1/48th of the shares subject to the option vested each month thereafter.
F2 1/48th of the shares subject to the option vested on September 10, 2018 and 1/48th of the shares subject to the option continue to vest each month thereafter, subject to the Reporting Person continuing as a service provider through each vest date.